R. Nil

1.6k total citations
47 papers, 1.2k citations indexed

About

R. Nil is a scholar working on Pharmacology, Experimental and Cognitive Psychology and Physiology. According to data from OpenAlex, R. Nil has authored 47 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Experimental and Cognitive Psychology and 10 papers in Physiology. Recurrent topics in R. Nil's work include Treatment of Major Depression (14 papers), Smoking Behavior and Cessation (10 papers) and Electroconvulsive Therapy Studies (8 papers). R. Nil is often cited by papers focused on Treatment of Major Depression (14 papers), Smoking Behavior and Cessation (10 papers) and Electroconvulsive Therapy Studies (8 papers). R. Nil collaborates with scholars based in Switzerland, Denmark and United Kingdom. R. Nil's co-authors include K. Bättig, K. B�ttig, Roberto Buzzi, Henrik Loft, Stuart Montgomery, Malcolm Lader, Dan J. Stein, Siegfried Kasper, David S. Baldwin and Malcolm Lader and has published in prestigious journals such as The British Journal of Psychiatry, Cellular and Molecular Life Sciences and Journal of Affective Disorders.

In The Last Decade

R. Nil

47 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Nil Switzerland 21 424 384 300 295 238 47 1.2k
Joseph Mendels United States 21 533 1.3× 373 1.0× 184 0.6× 448 1.5× 230 1.0× 33 1.5k
Barbara R. Haight United States 10 483 1.1× 158 0.4× 176 0.6× 412 1.4× 152 0.6× 12 1.2k
J. E. Christie United Kingdom 20 422 1.0× 288 0.8× 223 0.7× 501 1.7× 310 1.3× 42 1.9k
Ram Shrivastava United States 16 554 1.3× 443 1.2× 90 0.3× 577 2.0× 172 0.7× 28 1.3k
Maurizio Fava United States 13 536 1.3× 414 1.1× 115 0.4× 461 1.6× 165 0.7× 17 1.2k
P.M.J. Haffmans Netherlands 20 341 0.8× 359 0.9× 80 0.3× 455 1.5× 221 0.9× 44 1.2k
Helena Maria Calil Brazil 24 217 0.5× 143 0.4× 140 0.5× 335 1.1× 271 1.1× 59 1.4k
Rajinder Judge United States 15 421 1.0× 354 0.9× 128 0.4× 333 1.1× 358 1.5× 17 1.1k
Charles S. Wilcox United States 16 320 0.8× 272 0.7× 85 0.3× 275 0.9× 171 0.7× 27 806
Karl Rickels United States 14 381 0.9× 653 1.7× 116 0.4× 379 1.3× 334 1.4× 15 1.4k

Countries citing papers authored by R. Nil

Since Specialization
Citations

This map shows the geographic impact of R. Nil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Nil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Nil more than expected).

Fields of papers citing papers by R. Nil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Nil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Nil. The network helps show where R. Nil may publish in the future.

Co-authorship network of co-authors of R. Nil

This figure shows the co-authorship network connecting the top 25 collaborators of R. Nil. A scholar is included among the top collaborators of R. Nil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Nil. R. Nil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nil, R., et al.. (2016). Residual symptoms and functionality in depressed outpatients: A one-year observational study in Switzerland with escitalopram. Journal of Affective Disorders. 197. 245–250. 32 indexed citations
3.
Baldwin, David S., S.A. Montgomery, R. Nil, & M. Lader. (2005). Discontinuation symptoms in affective disorders. ePrints Soton (University of Southampton). 1 indexed citations
4.
Baldwin, David S., Stuart Montgomery, R. Nil, & Malcolm Lader. (2005). Discontinuation symptoms in depression and anxiety disorders. The International Journal of Neuropsychopharmacology. 10(1). 73–73. 95 indexed citations
5.
Kasper, Siegfried, Dan J. Stein, Henrik Loft, & R. Nil. (2005). Escitalopram in the treatment of social anxiety disorder. The British Journal of Psychiatry. 186(3). 222–226. 96 indexed citations
6.
Montgomery, Stuart, et al.. (2005). A 24-Week Randomized, Double-Blind, Placebo-Controlled Study of Escitalopram for the Prevention of Generalized Social Anxiety Disorder. The Journal of Clinical Psychiatry. 66(10). 1270–1278. 70 indexed citations
7.
Stein, Dan J., Siegfried Kasper, Elisabeth Wreford Andersen, R. Nil, & Malcolm Lader. (2004). Escitalopram in the treatment of social anxiety disorder: Analysis of efficacy for different clinical subgroups and symptom dimensions. Depression and Anxiety. 20(4). 175–181. 29 indexed citations
8.
Koponen, Hannu, Lotte Lauritzen, F. Rouillon, et al.. (2001). Prophylactic effect of citalopram in unipolar, recurrent depression. The British Journal of Psychiatry. 178(4). 304–310. 66 indexed citations
9.
Baumann, Pierre, et al.. (1998). A double-blind double-dummy study of citalopram comparing infusion versus oral administration. Journal of Affective Disorders. 49(3). 203–210. 20 indexed citations
10.
Seifritz, Erich, Matthias J. Müller, R. Nil, et al.. (1997). Effect of sleep deprivation on neuroendocrine response to a serotonergic probe in healthy male subjects. Journal of Psychiatric Research. 31(5). 543–554. 13 indexed citations
11.
Baumann, Pierre, R. Nil, Dominique Baettig, et al.. (1996). A Double-Blind, Placebo-Controlled Study of Citalopram With and Without Lithium in the Treatment of Therapy-Resistant Depressive Patients. Journal of Clinical Psychopharmacology. 16(4). 307–314. 132 indexed citations
12.
Nil, R., et al.. (1991). Ultralow-yield cigarettes and type of ventilation: The role of ventilation blocking. Pharmacology Biochemistry and Behavior. 40(4). 907–914. 9 indexed citations
13.
Nil, R., et al.. (1991). Nicotine yield as determinant of smoke exposure indicators and puffing behavior. Pharmacology Biochemistry and Behavior. 40(1). 139–149. 43 indexed citations
14.
Hasenfratz, M., R. Nil, & K. Bättig. (1990). Development of central and peripheral smoking effects over time. Psychopharmacology. 101(3). 359–365. 28 indexed citations
15.
Hasenfratz, M., Chantal Michel, R. Nil, & K. B�ttig. (1989). Can smoking increase attention in rapid information processing during noise? Electrocortical, physiological and behavioral effects. Psychopharmacology. 98(1). 75–80. 51 indexed citations
16.
Nil, R. & K. B�ttig. (1989). Separate effects of cigarette smoke yield and smoke taste on smoking behavior. Psychopharmacology. 99(1). 54–59. 39 indexed citations
17.
Nil, R., et al.. (1989). Type A behavior and psychophysiological reactivity: A 27-month follow-up. International Journal of Psychophysiology. 7(2-4). 286–287. 1 indexed citations
18.
Nil, R., et al.. (1986). Psychophysiological reactivity in Type A and B women during a rapid information processing task. Cellular and Molecular Life Sciences. 42(2). 126–131. 4 indexed citations
19.
Nil, R., et al.. (1986). Psychophysiologische Reaktivität in Beziehung zum Typ-A-Verhalten. Sozial- und Präventivmedizin. 31(4-5). 223–225. 1 indexed citations
20.
Nil, R., Roberto Buzzi, & K. Bättig. (1986). Effects of different cigarette smoke yields on puffing and inhalation: Is the measurement of inhalation volumes relevant for smoke absorption?. Pharmacology Biochemistry and Behavior. 24(3). 587–595. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026